We determined that SHP2 knockdown effectively increased the GC in IR‐induced HCC cells, promoted the activation of IRS‐2 and AKT, and inhibited ERK1/2 phosphorylation. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.